CPT code 11951 designates the injection of 1.1 cc to 5.0 cc of collagen into the subcutaneous layer of skin, representing a defined volume range for soft-tissue augmentation. This code matters nationally for consistent reporting of collagen-based augmentation procedures used in dermatology, plastic surgery, and reconstructive contexts. Accurate use of this code supports clinical documentation, appropriate reimbursement, and monitoring of utilization for cosmetic and reconstructive care.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides a national view of code definition, clinical context, common sites of service, and payer coverage considerations. Readers will find benchmarks for typical utilization ranges (where available), guidance on coding specificity tied to injected volume, and a summary of payer coverage themes. The report also outlines common modifier practice patterns and administrative considerations when billing collagen injections in outpatient and office-based procedural settings.

This summary is intended to give clinicians, billing professionals, and policy analysts a concise reference for CPT code 11951, clarifying what the code represents and what to expect in payer interactions and documentation requirements. Data not available in the input is noted where applicable.